SPRING Vision

Company Overview

Snapshot

Founded in January 2015, SPRING Vision operates with 11–50 employees. The company is developing ophthalmic equipment designed to offer overall patient diagnosis, a technology that was recognized in January 2015.

Business overview

SPRING Vision is a Health Tech & Life Sciences company focused on developing noninvasive, real-time, multispectral retinal imaging technology for automated diagnostics of ocular and systemic diseases. Its core product, the iCapture45, is a non-mydriatic and mydriatic multispectral retinal imager with a 45-degree field of view. The company serves the medical industry, enabling physicians to better differentiate between healthy and early-stage diseased retinal blood vessels, and is also evaluating a novel technology for portraying a retinal oxygenation map, coupled with AI, to transform modern-day medicine.

Company Intelligence Q&A

What is SPRING Vision's primary focus?

SPRING Vision is focused on developing technology for noninvasive, real-time, multispectral retinal imaging to enable automated diagnostics of ocular and systemic diseases.

What is the iCapture45?

The iCapture45 is SPRING Vision's proprietary non-mydriatic and mydriatic multispectral retinal imager, featuring a 45-degree field of view.

What future product is SPRING Vision developing?

SPRING Vision is working on the upcoming iCapture75, which will be a mydriatic imager with a larger field of view than its current product.

What is the strategic impact of SPRING Vision's technology?

SPRING Vision's microangiography, combined with retinal tissue oximetry, is expected to revolutionize the diagnostic ability and clinical application of retinal imaging, leading to improved forecasting of retinal and systemic diseases.

When was the ophthalmic equipment designed by SPRING Vision first recognized?

In January 2015, ophthalmic equipment designed by SPRING Vision to offer overall patient diagnosis was recognized.